Medivir's icon
Medivir

@medivir.se

Medivir is a research-based pharmaceutical company with a research focus on oncology and infectious diseases.

πŸ“’

Find anything inaccurate?

If you spot any mistakes on this brand profile, report to us.

Banner

Brand Logos

View all
Medivir's logos

Logo

PNG

Medivir's logos

Icon

JPEG

About

Description

Medivir AB is a leading biopharmaceutical company specializing in the development of innovative anti-tumor drugs. Their flagship product, Fostroxacitabine bralpamide (fostrox), is an orally administered drug that specifically targets liver cancers while minimizing its impact on the rest of the body. This unique liver-directed treatment has shown great potential in clinical trials and received positive opinions and designations from regulatory authorities.


Hepatocellular carcinoma (HCC), the most common form of liver cancer, is the primary focus of Medivir's research and development efforts. However, fostrox also holds promise for treating other forms of liver cancer, such as intrahepatic cholangiocarcinoma and liver metastases from other tumor sites. By leveraging its liver-targeted mechanism, fostrox achieves maximum concentration in the liver while minimizing systemic exposure, reducing the risk of side effects.


It works by converting into an active metabolite that causes DNA damage and cancer cell death, regardless of the tumor's mutations. Medivir's clinical development program for fostrox involves both monotherapy and combination therapy studies in patients with advanced liver cancer. Preliminary results have shown good safety, tolerability, and anti-tumor efficacy.


Ongoing research aims to further optimize the treatment and explore potential combinations with other drugs. As a forward-thinking biopharmaceutical company, Medivir is committed to advancing the field of liver cancer treatment and improving the lives of patients worldwide

Read more...

Brand collections

View all

Logos

Colors

Fonts

Images

Β© 2024 Brandfetch, SA. All rights reserved.